NCT04160806

Brief Summary

The aim of the present study is to investigate the effect of prefrontal transcranial Direct Current Stimulation (tDCS) on clinical severity, attentional bias and interoceptive accuracy in panic disorder (PD). The participants will be assigned to active and sham groups (1:1) and will receive 10 sessions of tDCS. The study will also examine if the effects may last for a month.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

November 8, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

October 4, 2022

Status Verified

October 1, 2022

Enrollment Period

2 years

First QC Date

November 8, 2019

Last Update Submit

October 1, 2022

Conditions

Keywords

Anxiety disordersPanic disorderTranscranial Direct Current StimulationInteroceptive accuracyAttention biasEmotion recognitionBrain Stimulation

Outcome Measures

Primary Outcomes (4)

  • Changes in Panic Disorder Severity Scale (PDSS) scores

    The PDSS consists of seven items, each rated on a 5-point scale, which ranges from 0 to 4. The items assess panic frequency, resulting distress, panic-focused anticipatory anxiety, phobic avoidance of situations and of physical sensations, impairment in occupational and social functioning. The overall assessment is made by a total score, which is calculated by summing the scores for all seven items. Minimum score is 0 and maximum score is 28. Higher scores indicate high levels of panic symptomatology. Reduction in score from baseline indicates clinical improvement of panic symptoms.

    Up to one month

  • Changes in Hamilton Anxiety Rating Scale (HAM-A) scores

    The Hamilton Anxiety Rating Scale (HAM-A) is a multiple item questionnaire used to provide an indication of anxiety severity. Higher scores indicate high levels of symptomatology. Minimum score is 0 and maximum score is 56. Reduction in score from baseline indicates clinical symptom improvement.

    Up to one month

  • Changes in Clinical Global Impression-Severity (CGI-S) scores

    Higher scores indicate the presence of high symptom severity. Decrease in scores from baseline reflects clinical symptom improvement. Minimum score is 1 and maximum score is 7. Patients will be classified as responders with a CGI-S = 1 or 2; and partial responders CGI-S = 3.

    Up to one month

  • Changes in performance on an attentional dot-probe task

    Computerized "dot-probe " attentional task will be used. Pairs of emotional faces (neutral/angry or neutral/happy) are randomly presented on a screen. Then, a probe is presented. Subjects are asked to indicate which side the probe approved and need to press the dot after the probe. Total time spent on Region of Interest (angry/neutral face) is measured. Attentional bias towards threat score is the subtraction of median reaction times (milliseconds) in congruent angry versus neutral trials from incongruent angry versus neutral trials. Minimum score is -1000 and maximum score is 1000. Positive scores indicate the presence of attentional vigilance towards threat whereas negative scores indicate an attentional avoidance towards threat.

    Up to one month

Secondary Outcomes (8)

  • Changes in Hamilton Depression Rating Scale (HAM-D) scores

    Up to one month

  • Changes in Beck Depression Inventory (BDI) scores

    Up to one month

  • Changes in Sheehan Disability Scale (SDS) Work/School scores

    Up to one month

  • Changes in Sheehan Disability Scale (SDS) Social Life scores

    Up to one month

  • Changes in Sheehan Disability Scale (SDS) Family Life/Home Responsibilities scores

    Up to one month

  • +3 more secondary outcomes

Study Arms (2)

Active Group

ACTIVE COMPARATOR

Left anodal/right anodal transcranial direct current stimulation over the dorsolateral prefrontal cortex

Device: Transcranial direct current stimulation

Sham Group

SHAM COMPARATOR

Sham transcranial direct current stimulation over the dorsolateral prefrontal cortex

Device: Transcranial direct current stimulation

Interventions

Participants will receive a total of 10 stimulation sessions. During each session, 2 milliAmpers of active or sham tDCS will be applied for 20 minutes over the dorsolateral prefrontal cortex (left anodal/right anodal).

Also known as: tDCS, Direct current stimulation, transcranial electrical stimulation
Active GroupSham Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with a primary diagnosis of Panic Disorder, as confirmed by the Structured Clinical Interview for the DSM-5 (SCID-5);
  • Patients currently on medication must be at the same stable dose(s) for one month prior to enrollment and be willing to continue at the same dose(s) through the duration of the study;
  • Right-hand dominancy assessed by Edinburgh Handedness Inventory;
  • Willingness and ability to comply with the requirements of the study protocol;
  • Naïve to tDCS.
  • or more years of education

You may not qualify if:

  • Illiteracy, deficient language or refusal to participate or being not able to follow instructions or complete study tasks;
  • Less than 5 years of education
  • Individuals with any current or lifetime diagnosis of other Axis I disorders, as confirmed by the Structured Clinical Interview for the DSM-5 (SCID-5);
  • History of substance or psychoactive compound use,with the exception of nicotine consumption;
  • The presence of mental retardation diagnosis (previously identified)
  • Individuals with a clinically defined neurological disorder, with an increased risk of seizure for any reason, with a history of treatment with rTMS, deep brain stimulation for any disorder will be excluded;
  • Any personal or family history (1st degree relatives) of seizures other than febrile childhood seizures
  • Personal history of head trauma that resulted in loss of consciousness for \> 5 minutes and retrograde amnesia for \> 30 minutes;
  • Significant hearing loss or visual impairment;
  • Diagnosis of any serious or uncontrolled medical condition such as chronic obstructive pulmonary disease, congestive heart failure or renal failure;
  • Skin diseases that could potentially cause irritations under electrodes;
  • Patients missing two consecutive protocol sessions;
  • Patients with cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute, unstable cardiac disease, with intracranial implants (e.g. aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department Of Psychiatry, Istanbul University

Istanbul, 34060, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Panic DisorderAnxiety Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Raşit Tükel, Professor

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

November 8, 2019

First Posted

November 13, 2019

Study Start

November 1, 2019

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

October 4, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations